Renske Kruizinga1, Iris D Hartog2, Marc Jacobs2, Joost G Daams3, Michael Scherer-Rath4, Johannes B A M Schilderman4, Mirjam A G Sprangers2, Hanneke W M Van Laarhoven1. 1. Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 2. Department of Medical Psychology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 3. Medical Library, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 4. Faculty of Philosophy, Theology and Religious Studies, Radboud University Nijmegen, Nijmegen, The Netherlands.
Abstract
OBJECTIVE: The aim of this study was to examine the effect of spiritual interventions on quality of life of cancer patients. METHODS: We conducted our search on June 6, 2014 in Medline, PsycINFO, Embase, and PubMed. All clinical trials were included that compared standard care with a spiritual intervention that addressed existential themes using a narrative approach. Study quality was evaluated by the Cochrane Risk of Bias Tool. RESULTS: A total of 4972 studies were identified, of which 14 clinical trials (2050 patients) met the inclusion criteria, and 12 trials (1878 patients) were included in the meta-analysis. The overall risk of bias was high. When combined, all studies showed a moderate effect (d) 0.50 (95% CI = 0.20-0.79) 0-2 weeks after the intervention on overall quality of life in favor of the spiritual interventions. Meta-analysis at 3-6 months after the intervention showed a small insignificant effect (0.14, 95% CI = -0.08 to 0.35). Subgroup analysis including only the western studies showed a small effect of 0.17 (95% CI = 0.05-0.29). Including only studies that met the allocation concealment criteria showed an insignificant effect of 0.14 (95% CI = -0.05 to 0.33). CONCLUSIONS: Directly after the intervention, spiritual interventions had a moderate beneficial effect in terms of improving quality of life of cancer patients compared with that of a control group. No evidence was found that the interventions maintained this effect up to 3-6 months after the intervention. Further research is needed to understand how spiritual interventions could contribute to a long-term effect of increasing or maintaining quality of life.
OBJECTIVE: The aim of this study was to examine the effect of spiritual interventions on quality of life of cancerpatients. METHODS: We conducted our search on June 6, 2014 in Medline, PsycINFO, Embase, and PubMed. All clinical trials were included that compared standard care with a spiritual intervention that addressed existential themes using a narrative approach. Study quality was evaluated by the Cochrane Risk of Bias Tool. RESULTS: A total of 4972 studies were identified, of which 14 clinical trials (2050 patients) met the inclusion criteria, and 12 trials (1878 patients) were included in the meta-analysis. The overall risk of bias was high. When combined, all studies showed a moderate effect (d) 0.50 (95% CI = 0.20-0.79) 0-2 weeks after the intervention on overall quality of life in favor of the spiritual interventions. Meta-analysis at 3-6 months after the intervention showed a small insignificant effect (0.14, 95% CI = -0.08 to 0.35). Subgroup analysis including only the western studies showed a small effect of 0.17 (95% CI = 0.05-0.29). Including only studies that met the allocation concealment criteria showed an insignificant effect of 0.14 (95% CI = -0.05 to 0.33). CONCLUSIONS: Directly after the intervention, spiritual interventions had a moderate beneficial effect in terms of improving quality of life of cancerpatients compared with that of a control group. No evidence was found that the interventions maintained this effect up to 3-6 months after the intervention. Further research is needed to understand how spiritual interventions could contribute to a long-term effect of increasing or maintaining quality of life.
Authors: Michelle B Riba; Kristine A Donovan; Barbara Andersen; IIana Braun; William S Breitbart; Benjamin W Brewer; Luke O Buchmann; Matthew M Clark; Molly Collins; Cheyenne Corbett; Stewart Fleishman; Sofia Garcia; Donna B Greenberg; Rev George F Handzo; Laura Hoofring; Chao-Hui Huang; Robin Lally; Sara Martin; Lisa McGuffey; William Mitchell; Laura J Morrison; Megan Pailler; Oxana Palesh; Francine Parnes; Janice P Pazar; Laurel Ralston; Jaroslava Salman; Moreen M Shannon-Dudley; Alan D Valentine; Nicole R McMillian; Susan D Darlow Journal: J Natl Compr Canc Netw Date: 2019-10-01 Impact factor: 11.908
Authors: Gina Andrade Abdala; Maria Dyrce Dias Meira; Gabriel Tagliari Rodrigo; Morenilza Bezerra da Conceição Fróes; Matheus Souza Ferreira; Sammila Andrade Abdala; Harold George Koenig Journal: J Relig Health Date: 2021-02
Authors: Alissa Stavig; Lynn A Bowlby; John P Oliver; Katherine K Henderson; Jan Dillard; Elissa Nickolopoulos; Patrick Hemming Journal: J Gen Intern Med Date: 2021-01-22 Impact factor: 5.128
Authors: Albert Kamp; Zarah Bood; Michael Scherer-Rath; Yvonne Weeseman; Nirav Christophe; Henny Dörr; José Sanders; Mirjam Sprangers; Esther Helmich; Liesbeth Timmermans; Ellen van Wolde; Hanneke W M van Laarhoven Journal: J Cancer Surviv Date: 2021-06-15 Impact factor: 4.062
Authors: Lucy Ellen Selman; Lisa Jane Brighton; Shane Sinclair; Ikali Karvinen; Richard Egan; Peter Speck; Richard A Powell; Ewa Deskur-Smielecka; Myra Glajchen; Shelly Adler; Christina Puchalski; Joy Hunter; Nancy Gikaara; Jonathon Hope Journal: Palliat Med Date: 2017-10-12 Impact factor: 4.762